(Q38006928)

26 August 2017

Systemic inflammation and comorbidities in chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

26 August 2017

1 reference

1 reference

systemic inflammation

1 reference

Rosa Faner

2

0 references

author name string

Alvar Agustí

series ordinal

1

1 reference

26 August 2017

1 May 2012

1 reference

Proceedings of the American Thoracic Society

26 August 2017

1 reference

26 August 2017

9

1 reference

26 August 2017

43-46

1 reference

26 August 2017

2

1 reference

COPD, a multicomponent disease: implications for management

26 August 2017

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

A dynamic network approach for the study of human phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Systemic manifestations and comorbidities of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Characterisation of COPD heterogeneity in the ECLIPSE cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Current controversies and future perspectives in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Systemic effects in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Systemic Inflammation and COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Systemic inflammation in chronic obstructive pulmonary disease: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Systemic inflammation and mortality in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should).

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

A network-based analysis of systemic inflammation in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Points of control in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Network medicine: a network-based approach to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Pharmacological actions of statins: potential utility in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Previous lung diseases and lung cancer risk: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Recent trends in lung cancer and its association with COPD: an analysis using the UK GP Research Database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

The relationship between the insulin-like growth factor-1 axis, weight loss, an inflammation-based score and survival in patients with inoperable non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE)

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

Systemic effects of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

From COPD to chronic systemic inflammatory syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FPATS.201108-050MS

10.1513/PATS.201108-050MS

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference

PubMed ID

22550240